{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:10:14Z","timestamp":1788765014411,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Bovay Foundation and the Levy-Longenbaugh Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12015-026-11194-6","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:22:02Z","timestamp":1784355722000},"page":"2982-2984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP1 Mimetics and Stem Cells: An Intersection of Metabolic and Regenerative Medicine"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3743-7869","authenticated-orcid":false,"given":"Mikhail G.","family":"Kolonin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"1","key":"11194_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41591-025-04124-5","volume":"32","author":"DJ Drucker","year":"2026","unstructured":"Drucker, D. J. (2026). The expanding landscape of GLP-1 medicines. Nature Medicine, 32(1), 47\u201357.","journal-title":"Nature Medicine"},{"key":"11194_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010065","author":"SS Wilbon","year":"2023","unstructured":"Wilbon, S. S., & Kolonin, M. G. (2023). GLP1 receptor agonists-effects beyond obesity and diabetes. Cells. https:\/\/doi.org\/10.3390\/cells13010065","journal-title":"Cells"},{"issue":"2","key":"11194_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1677\/joe.1.06078","volume":"186","author":"L Bai","year":"2005","unstructured":"Bai, L., Meredith, G., & Tuch, B. E. (2005). Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells. Journal Of Endocrinology, 186(2), 343\u2013352.","journal-title":"Journal Of Endocrinology"},{"issue":"3","key":"11194_CR4","doi-asserted-by":"publisher","first-page":"E494","DOI":"10.1152\/ajpendo.00116.2011","volume":"301","author":"C Sanz","year":"2011","unstructured":"Sanz, C., & Blazquez, E. (2011). New gene targets for glucagon-like peptide-1 during embryonic development and in undifferentiated pluripotent cells. American Journal of Physiology, Endocrinology and Metabolism, 301(3), E494-503.","journal-title":"American Journal of Physiology, Endocrinology and Metabolism"},{"issue":"8","key":"11194_CR5","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1089\/ten.2006.12.2105","volume":"12","author":"F Yue","year":"2006","unstructured":"Yue, F., et al. (2006). Glucagon-like peptide-1 differentiation of primate embryonic stem cells into insulin-producing cells. Tissue Engineering, 12(8), 2105\u20132116.","journal-title":"Tissue Engineering"},{"issue":"3","key":"11194_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/MPA.0b013e3181bc30dd","volume":"39","author":"H Hui","year":"2010","unstructured":"Hui, H., et al. (2010). Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways. Pancreas, 39(3), 315\u2013322.","journal-title":"Pancreas"},{"issue":"1","key":"11194_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12015-025-11002-7","volume":"22","author":"L Weber","year":"2026","unstructured":"Weber, L., et al. (2026). The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review. Stem Cell Rev Rep, 22(1), 26\u201346.","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"11194_CR8","doi-asserted-by":"publisher","first-page":"E634","DOI":"10.1152\/ajpendo.00460.2009","volume":"298","author":"C Sanz","year":"2010","unstructured":"Sanz, C., et al. (2010). Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow. American Journal Of Physiology. Endocrinology And Metabolism, 298(3), E634\u2013E643.","journal-title":"American Journal Of Physiology. Endocrinology And Metabolism"},{"issue":"1","key":"11194_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24633-0","volume":"15","author":"H Liu","year":"2025","unstructured":"Liu, H., et al. (2025). GLP-1RA in JBMMSCs promoted osteogenic differentiation via modulating CREB and BRD4 signaling mediated proliferation and stemness. Scientific Reports, 15(1), Article 40773.","journal-title":"Scientific Reports"},{"key":"11194_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2023.170974","volume":"163","author":"S Zhai","year":"2023","unstructured":"Zhai, S., et al. (2023). Glucagon-like peptide-1 receptor promotes osteoblast differentiation of dental pulp stem cells and bone formation in a zebrafish scale regeneration model. Peptides, 163, Article 170974.","journal-title":"Peptides"},{"issue":"1","key":"11194_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s11658-026-00867-2","volume":"31","author":"Y Shen","year":"2026","unstructured":"Shen, Y., et al. (2026). The promoting roles of GLP1R and GIPR in stemness maintenance and multiple lineage-specific differentiation of PDLSCs. Cellular & Molecular Biology Letters, 31(1), 22.","journal-title":"Cellular & Molecular Biology Letters"},{"issue":"1","key":"11194_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-022-01486-9","volume":"21","author":"A Sforza","year":"2022","unstructured":"Sforza, A., et al. (2022). Liraglutide preserves CD34(+) stem cells from dysfunction Induced by high glucose exposure. Cardiovasc Diabetol, 21(1), 51.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"11194_CR13","doi-asserted-by":"publisher","first-page":"H370","DOI":"10.1152\/ajpheart.00257.2024","volume":"327","author":"B Park","year":"2024","unstructured":"Park, B., et al. (2024). GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes. American Journal Of Physiology Heart And Circulatory Physiology, 327(2), H370\u2013H376.","journal-title":"American Journal Of Physiology Heart And Circulatory Physiology"},{"issue":"2","key":"11194_CR14","doi-asserted-by":"publisher","first-page":"BR35","DOI":"10.12659\/MSM.881383","volume":"17","author":"X Xiao-Yun","year":"2011","unstructured":"Xiao-Yun, X., et al. (2011). Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation. Medical Science Monitor, 17(2), BR35\u201341.","journal-title":"Medical Science Monitor"},{"issue":"3","key":"11194_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058784","volume":"8","author":"V Parthsarathy","year":"2013","unstructured":"Parthsarathy, V., & Holscher, C. (2013). Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model. PLoS One, 8(3), Article e58784.","journal-title":"PLoS One"},{"key":"11194_CR16","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1017\/neu.2025.4","volume":"37","author":"HCT Au","year":"2025","unstructured":"Au, H. C. T., et al. (2025). Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: A systematic review. Acta Neuropsychiatrica, 37, e50.","journal-title":"Acta Neuropsychiatrica"},{"key":"11194_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2026.156547","volume":"178","author":"M Li","year":"2026","unstructured":"Li, M., et al. (2026). The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential. Metabolism, 178, Article 156547.","journal-title":"Metabolism"},{"issue":"1","key":"11194_CR18","doi-asserted-by":"publisher","first-page":"e13677","DOI":"10.1002\/jcsm.13677","volume":"16","author":"VJ Old","year":"2025","unstructured":"Old, V. J., et al. (2025). The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review. J Cachexia Sarcopenia Muscle, 16(1), e13677.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"11194_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-026-00383-9","author":"MJ Corley","year":"2026","unstructured":"Corley, M. J., et al. (2026). Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER study. NPJ Aging. https:\/\/doi.org\/10.1038\/s41514-026-00383-9","journal-title":"NPJ Aging"},{"key":"11194_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156113","volume":"164","author":"P Karakasis","year":"2025","unstructured":"Karakasis, P., et al. (2025). Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis. Metabolism, 164, Article 156113.","journal-title":"Metabolism"},{"key":"11194_CR21","doi-asserted-by":"publisher","DOI":"10.1113\/JP289449","author":"S Jeromson","year":"2025","unstructured":"Jeromson, S., et al. (2025). Semaglutide impacts skeletal muscle to a similar extent as caloric restriction in mice with diet-induced obesity. Journal of Physiology. https:\/\/doi.org\/10.1113\/JP289449","journal-title":"Journal of Physiology"},{"issue":"12","key":"11194_CR22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/s42255-020-00320-4","volume":"2","author":"Z Gao","year":"2020","unstructured":"Gao, Z., et al. (2020). Age-associated telomere attrition in adipocyte progenitors predisposes to metabolic disease. Nat Metab, 2(12), 1482\u20131497.","journal-title":"Nat Metab"},{"issue":"6S","key":"11194_CR23","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/DSS.0000000000005175","volume":"52","author":"M Firsowicz","year":"2026","unstructured":"Firsowicz, M., et al. (2026). Cutaneous Variations in Stem-Cell Population in Those on GLP1-Receptor Agonists: A Comparative Controlled Study. Dermatologic Surgery, 52(6S), S39\u2013S44.","journal-title":"Dermatologic Surgery"},{"key":"11194_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mce.2014.12.021","volume":"402","author":"G Cantini","year":"2015","unstructured":"Cantini, G., et al. (2015). Effect of liraglutide on proliferation and differentiation of human adipose stem cells. Molecular And Cellular Endocrinology, 402, 43\u201350.","journal-title":"Molecular And Cellular Endocrinology"},{"issue":"10","key":"11194_CR25","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1073\/pnas.1401861111","volume":"111","author":"AM Kershner","year":"2014","unstructured":"Kershner, A. M., et al. (2014). Discovery of two GLP-1\/Notch target genes that account for the role of GLP-1\/Notch signaling in stem cell maintenance. Proceedings of the National Academy of Sciences of the United States of America, 111(10), 3739\u201344.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"11194_CR26","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1210\/clinem\/dgaf401","volume":"110","author":"M Couldwell","year":"2025","unstructured":"Couldwell, M., Tidwell, A. J., & Taylor, A. E. (2025). Effect of GLP1 Agonists on Reproduction. Journal Of Clinical Endocrinology And Metabolism, 110(11), 3009\u20133024.","journal-title":"Journal Of Clinical Endocrinology And Metabolism"},{"key":"11194_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15093204","author":"MM Abedi","year":"2026","unstructured":"Abedi, M. M., et al. (2026). GLP-1 receptor agonists, fertility restoration, and reproductive safety in women of reproductive age: A narrative review. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm15093204","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"11194_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100813","volume":"3","author":"AD Gutierrez","year":"2022","unstructured":"Gutierrez, A. D., et al. (2022). Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes. Cell Reports Medicine, 3(11), Article 100813.","journal-title":"Cell Reports Medicine"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11194-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11194-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11194-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:58:55Z","timestamp":1788764335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11194-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11194"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11194-6","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to update the Funding statement.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}